English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Glaxo Smith Kline
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
Bristol Myers Squibb funds $2.25M cervical cancer project in Malawi
+
Pharmaceuticals
Patient Daily
| Oct 21, 2024
Baylor professors Bottazzi and Davis elected to National Academy of Medicine
+
Pharmaceuticals
Patient Daily
| Oct 22, 2024
American Lung Association welcomes three leaders to Georgia board
+
Pharmaceuticals
Patient Daily
| Oct 24, 2024
Dr. Huda Zoghbi honored by American Academy for her contributions to science
